Compare PHR & PTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PHR | PTA |
|---|---|---|
| Founded | 2005 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2019 | N/A |
| Metric | PHR | PTA |
|---|---|---|
| Price | $16.49 | $19.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $31.76 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 159.2K |
| Earning Date | 12-08-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.31% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $463,205,000.00 | N/A |
| Revenue This Year | $15.41 | N/A |
| Revenue Next Year | $14.33 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.33 | N/A |
| 52 Week Low | $15.41 | $15.84 |
| 52 Week High | $32.76 | $19.67 |
| Indicator | PHR | PTA |
|---|---|---|
| Relative Strength Index (RSI) | 34.60 | 48.51 |
| Support Level | $16.17 | $19.10 |
| Resistance Level | $17.33 | $19.40 |
| Average True Range (ATR) | 0.55 | 0.15 |
| MACD | 0.19 | 0.02 |
| Stochastic Oscillator | 40.43 | 75.76 |
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its primary investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.